Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-14
1996-10-01
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514200, 514212, 5142315, 5142338, 5142345, 5142352, 5142355, 5142358, 5142368, 5142372, 514252, 514256, 514258, 514266, 514303, 514314, 514316, 514318, 514319, 514321, 514423, 548530, 548540, 540200, 540354, 540480, 540483, 540544, 540553, 540597, 540600, 540603, 546118, 546152, 546190, 546193, 546198, 546208, 546209, 546210, 546211, 546212, 546214, 544121, 544127, 544128, 544129, 544130, 544133, 544135, 544137, 544139, 544141, 544238, 544242, 544277, 544283, 544236, A61K 31445, C07D20709, C07D21126
Patent
active
055611460
ABSTRACT:
Thrombin inhibitors are provided which have the formula ##STR1## wherein Z is a thrombin inhibitor substructure containing distal and proximal binding site residues; and
REFERENCES:
patent: 4161522 (1979-07-01), Hamburger
patent: 4258192 (1981-03-01), Okamoto et al.
patent: 4346078 (1982-08-01), Bajusz et al.
patent: 4904661 (1990-02-01), Pilgrim et al.
patent: 5002964 (1991-03-01), Loscalzo
patent: 5217705 (1993-06-01), Reno et al.
patent: 5264420 (1993-11-01), Duggan
patent: 5354738 (1994-10-01), Tjoeng
Robert M. Knabb et al, "In Vivo Characterization of a New Synthetic Thrombin Inhibitor," Thrombosis and Hemostasis (1992) 67, 56-59.
Charles V. Jackson et al, "Pharmacological Assessment of the Antithrombotic Activity of the Peptide Thrombin Inhibitor, D-Methyl-Phenylalanyl-Prolyl-Arginal (GYKI-14766), in a Canine Model of Coronary Artery Thrombosis," J. Pharm. Exp. Ther. (1992) 261, 546-552.
Shauman et al. "Highly selective thrombin inhibitors" J. Med. Chem. 36 pp. 314-319 (1993).
Bajusz et al. "Highly selective and active anticoagulants" J. Med. Chem. 33 pp. 1729-1735 (1990).
Banner et al. "Serine protease:3D structure, mechanism of action and inhibitors" Prospect. Med. Chem. Verlag Publishing, Eds Testa Bernard, pp. 27-43 (1993).
Das Jagabandhu
Han Wen-Ching
Iwanowicz Edwin J.
Kim Kyoung S.
Kimball Spencer D.
Bristol--Myers Squibb Company
Chang Ceila
Rodney Burton
LandOfFree
Modified guanidino and amidino thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified guanidino and amidino thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified guanidino and amidino thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1502169